NDC Package 70954-158-30 Clorazepate Dipotassium

Tablet Oral - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
70954-158-30
Package Description:
30 TABLET in 1 BOTTLE
Product Code:
Proprietary Name:
Clorazepate Dipotassium
Non-Proprietary Name:
Clorazepate Dipotassium
Substance Name:
Clorazepate Dipotassium
Usage Information:
Clorazepate is used to treat anxiety, acute alcohol withdrawal, and seizures. This medication belongs to a class of drugs called benzodiazepines which act on the brain and nerves (central nervous system) to produce a calming effect. It works by enhancing the effects of a certain natural chemical in the body (GABA).
11-Digit NDC Billing Format:
70954015830
Billing Unit:
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
NDC to RxNorm Crosswalk:
30 EA
NDC to RxNorm Crosswalk:
  • RxCUI: 197464 - clorazepate dipotassium 15 MG Oral Tablet
  • RxCUI: 197465 - clorazepate dipotassium 3.75 MG Oral Tablet
  • RxCUI: 197466 - clorazepate dipotassium 7.5 MG Oral Tablet
  • Product Type:
    Human Prescription Drug
    Labeler Name:
    Ani Pharmaceuticals, Inc.
    Dosage Form:
    Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
    Administration Route(s):
  • Oral - Administration to or by way of the mouth.
  • Active Ingredient(s):
    DEA Schedule:
    Schedule IV (CIV) Substances
    Sample Package:
    No
    FDA Application Number:
    ANDA213730
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    06-16-2022
    Listing Expiration Date:
    12-31-2025
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 70954-158-30?

    The NDC Packaged Code 70954-158-30 is assigned to a package of 30 tablet in 1 bottle of Clorazepate Dipotassium, a human prescription drug labeled by Ani Pharmaceuticals, Inc.. The product's dosage form is tablet and is administered via oral form.

    Is NDC 70954-158 included in the NDC Directory?

    Yes, Clorazepate Dipotassium with product code 70954-158 is active and included in the NDC Directory. The product was first marketed by Ani Pharmaceuticals, Inc. on June 16, 2022 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 70954-158-30?

    The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units. The calculated billable units for this package is 30.

    What is the 11-digit format for NDC 70954-158-30?

    The 11-digit format is 70954015830. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-270954-158-305-4-270954-0158-30